Covance and INphoton LLC today announced a collaborative relationship which will grant Covance exclusive global access to INphoton’s intravital microscopy imaging technology and expertise.
The new services offered as a result of the companies’ collaboration will include intravital microscopy and associated 3D image reconstruction and will offer clients:
Dr. Michael A. Dorato, Vice President of Covance Discovery Services, stated, “The unique imaging capabilities of both organizations will allow our scientific teams to integrate intravital microscopy with Covance’s extensive molecular and anatomical imaging expertise focusing on specific client queries in the early discovery/development phase. The ultimate benefit is enabling our clients to make resource- and time-saving decisions on compounds earlier in the drug development process.”
Intravital microscopy is a technique that provides quantitative, in vivo molecular imaging at subcellular resolution, resulting in a cost-effective approach to accelerate preclinical drug development. State-of-the-art multiphoton microscopy combined with novel surgical techniques and multiple fluorophores allow in vivo imaging at subcellular resolution. These high-content imaging technologies provide visibility of quantitative organ, cellular and subcellular distribution of potential therapeutic compounds as well as physiologic data, facilitating an understanding of efficacy and safety. Clients have found that the insights provided by in vivo multiphoton microscopy provide for more in-depth decision making data.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.